Cathie Wood's ARK ETF bolsters biotech, trims defense stock

Cathie Wood's ARK ETFs, in their latest daily trades, significantly bolstered positions in the biotech sector, including a $21.5 million purchase of GeneDx Holdings and substantial buys in CRISPR Therapeutics and Beam Therapeutics, underscoring a strong conviction in genomic research and gene-editing technologies. Concurrently, ARK increased its fintech exposure with a $14 million investment in Robinhood Markets and diversified into agriculture via Deere & Co, while strategically divesting $7.9 million from Kratos Defense and Security Solutions, indicating a broader shift towards disruptive innovation and away from defense.

Analysis

ARK Invest's trading activity on August 18th, 2025, demonstrates a significant and continued capital allocation towards high-conviction themes in biotechnology and fintech, while simultaneously reducing exposure to the defense sector. The fund's largest single investment was a $21.5 million purchase of GeneDx Holdings (WGS), strongly reinforcing its bullish outlook on genomic research. This was further supported by substantial acquisitions in other gene-editing and precision medicine companies, including $10.6 million in CRISPR Therapeutics (CRSP) and $7.0 million in Beam Therapeutics (BEAM), continuing a pattern of accumulation from the prior week. Concurrently, ARK increased its position in Robinhood Markets (HOOD) by $14.1 million, signaling growing confidence in the fintech's business model. In a move towards diversification into tech-enabled legacy industries, the fund also invested $5.0 million in Deere & Co (DE). In contrast, the sale of $8.0 million in Kratos Defense and Security Solutions (KTOS) suggests a strategic pivot away from defense, likely to fund these more concentrated bets on disruptive innovation.

Key Decisions for Investors

• Investors aligned with ARK's high-growth strategy should note the concentrated, multi-million dollar inflows into the genomics sector, specifically WGS, CRSP, and BEAM, as these represent the fund's highest-conviction area.
• The divestment from Kratos Defense (KTOS) signals a clear strategic shift; investors holding KTOS as part of an ARK-aligned portfolio should re-evaluate their position.
• ARK's continued accumulation of Robinhood (HOOD) and its new position in Deere & Co (DE) suggest that opportunities are being identified in both disruptive fintech and the technological transformation of established industrial sectors.
• Consider the high volatility inherent in these concentrated positions and assess if the risk-reward profile of ARK's targeted companies aligns with personal investment horizons and tolerance.